Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VivoSensMedical is a private German medtech and digital diagnostics company developing sensor-based medical devices and medical algorithms built around core body temperature as a biomarker. Its lead commercial product, OvulaRing/OvulaRing+, is a CE-certified Class IIa vaginal biosensor and software system used for objective cycle and fertility diagnostics, including ovulation timing, fertile-window determination, and assessment of cycle abnormalities. The company positions its broader technology platform, Cyclofertilography, as a scalable precision-diagnostics approach applicable not only to women's health and reproductive medicine but also to chronobiology and autoimmune disease monitoring. VivoSensMedical has conducted clinical and observational work with academic collaborators and has reported reimbursement arrangements with several German health insurers for OvulaRing-based care. The business appears focused on commercial women's health diagnostics today while continuing R&D and platform expansion into adjacent indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VivoSensMedical.